GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Procyon PCYN · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.18

—

Close of 27 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Procyon

From its filings with the US Securities and Exchange Commission

SEC filings

Procyon is based in Clearwater, Florida and is incorporated in Colorado. Its shares trade on OTC under the ticker PCYN. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 30 June 2024, it reported revenue of $5.0m and a net loss of $341,140. At that date it held total assets of $3.2m and shareholders' equity of $2.3m.

In its own words

Procyon, a Colorado corporation, was incorporated on March 19, 1987, and was deemed a development stage company until May 1996, when we acquired Amerx, a corporation based in Oldsmar, Florida, which was wholly owned by John C. Anderson, our deceased Chief Executive Officer. AMERX® develops and markets proprietary medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Historically, AMERX's products are sold through distributors to healthcare institutions including hospitals, wound care clinics, nursing homes and home health care agencies and to retailers including national and regional chain stores and pharmacies and to healthcare practitioners who treat wounds. Sirius no longer has any material operations.

Major product lines - AMERX®, AMERIGEL® , HELIX3 Bioactive Collagen®, EXTREMIT-EASE® Compression Garment and Advantagen® Surgical Collagen.

AMERX markets a proprietary line of AMERIGEL® advanced skin and wound care products made with Oakin®, proven to promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. These products have become the core foundation for AMERX's growth.

Quoted from its 10-K, filed 25 Oct 2024. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
11 Dec 1996
Employees
19
Head office
1300 S HIGHLAND AVE, CLEARWATER, FL, 33756
Incorporated in
CO
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Ms. Regina AndersonChairwoman of the Board, since 2005$75,065
  • Mr. Justice AndersonChief Executive Officer, Director, President of Procyon, and Vice-President Marketing of Amerx Health Care Corp., since 2005$290,110
  • Mr. James AndersonChief Financial Officer, Director; Procyon Vice President - Operations of Amerx Health Care Corp., since 2005$212,004
  • Mr. George BorakVice President - Sales, AMERX Health Care Corp$206,960
  • Mr. Steven MccomasIndependent Director
  • Ms. Monica McCulloughIndependent Director
  • Mr. Fred SuggsIndependent Director
  • Mr. Joseph TreshlerIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Procyon Corp possesses several key strengths that contribute to its success in the market:

Weaknesses

  • Despite its strengths, Procyon Corp also faces certain weaknesses that may hamper its growth:

Opportunities

  • The following opportunities can greatly benefit Procyon Corp's future prospects:

Threats

  • Procyon Corp must be cautious of the following threats in order to maintain its competitive edge:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.